HomeNewsEconomyPolicyCoronavirus Impact | Air quality improves in India, finally

Coronavirus Impact | Air quality improves in India, finally

When governments rebuild their economy, it is likely that clean energy may take a backseat.

March 25, 2020 / 16:14 IST
Story continues below Advertisement


As the entire country observed 'Janata Curfew' on March 22, there was a significant dip in air pollution levels across the country. Delhi, Bengaluru, Kolkata and Lucknow witnessed clean air as the Air Quality Index stayed within two digits.

According to data by the Central Pollution Control Board, air pollutants in Delhi was at 126 micrograms per cubic metre at 1 AM on March 22, which nearly halved by 1 PM. However, pollution levels in Ghaziabad, Greater Noida and Noida remained at 'poor' and 'moderate' despite shutdown of commercial establishments and industrial activities.

Story continues below Advertisement

Kolkata recorded a significant improvement in air quality.  The PM 2.5 air quality index (AQI) was 'satisfactory' in all the automated air monitoring stations in the city during the day, an official of the West Bengal Pollution Control Board said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show